Dorothy Air Named to EMTEC Board

CINCINNATI – Dorothy Air, PhD, associate senior vice president for entrepreneurial affairs at the University of Cincinnati (UC), has been elected to the board of the Edison Materials Technology Center (EMTEC).

 

EMTEC, headquartered in Dayton, Ohio, is a non-profit, member-based organization serving Ohio that develops business and technology strategies and sponsors, coordinates and manages collaborative projects and programs leading to commercialization or new business formation.

 

EMTEC focuses on assistance for potentially high-growth materials technologies and provides technical coordination and commercialization assistance to Ohio’s industry, universities and government labs to strengthen the state’s industrial competitiveness in automotive, metal casting, nanomaterials, polymers, composites, biomaterials and alternative energy markets.

 

In her role at UC, Air assists UC faculty in start-up company activities related to new technology development, develops commercialization and business resources for the university, and creates entrepreneurial programs to promote entrepreneurship in the university and community.

 

The election of Air and other new board members, “when combined with our current board members, provides a balanced base of academia and technologically focused industrial/manufacturing expertise,” said Frank Svet, chief executive officer of EMTEC. “We are pleased to have these new board members join us to continue helping EMTEC and our members to additional technology and business growth.”

Tags

Related Stories

1

Study: Additional radiation for liver cancer does not increase toxicity

March 10, 2026

New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.

2

Is uACR the key to cardiovascular and kidney disease prevention?

March 8, 2026

As a precision biomarker, the urinary albumin-to-creatinine ratio (uACR) can guide physicians toward personalized, patient-centered prevention and treatment of both cardiovascular disease (CVD) and chronic kidney disease (CKD), according to new data published in the Journal of Internal Medicine.

3

Driven by her own pain

March 8, 2026

Endometriosis is a painful and often debilitating disease that affects an estimated 6.5 million women in the U.S. It occurs when tissue similar to the lining of the uterus grows outside of it, causing pain, inflammation and sometimes infertility. Now a University of Cincinnati College of Medicine researcher is developing what is believed to be the first at-home diagnostic test.